 |
Building on Its Global Momentum, the Brand Completes Official HSA Notification in Singapore and Secures Full HSA/FSA Payment Support in the US
HONG KONG, Sept. 21, 2026 /PRNewswire/ — Bened Life, a global leader in psychobiotic innovation, saw its flagship product Neuralli™ MP win two authoritative industry and medical honors in Hong Kong. At the Healthcare Professionals Favorite Brand Award 2026, Neuralli™ MP stood out among numerous probiotic brands to win the top honor in the Probiotics category, the “Healthcare Professional Choice Probiotic Award.” Separately, in 2025, Neuralli™ MP was further honored with the Best Psychobiotic Brand of the Year award, presented by the Hong Kong Commercial Times (HKCT), underscoring the brand’s leading position in the psychobiotics field.
Behind these two honors lies real-world validation from the healthcare professional community. A survey by the Health Research Centre among HK healthcare professionals shows that after 1 month of Neuralli™ MP usage:
- Over 90% of surveyed HK HCPs recommend¹
- 94.3% of surveyed HK HCPs reported improved focus²
- 93.1% of surveyed HK HCPs reported reduced work stress³
“These two awards mean a lot to us — they reflect real recognition from Hong Kong’s healthcare community and business sector alike, for our scientific evidence and quality standards,” said Frankie Cheng, CEO of Bened Life. “But for a science-driven brand like ours, nothing means more than earning the trust of frontline healthcare professionals.”
As public awareness of Brain-Gut Axis health keeps growing, Neuralli™ MP continues to earn trust across Hong Kong and the wider APAC market through its strong scientific evidence and high quality standards.
At the core of Neuralli™ MP is PS128™ (Lactiplantibacillus plantarum PS128™), a probiotic strain extensively studied for its role in the gut-brain connection. PS128™ is a novel psychobiotic that appears to balance the “happy hormones” serotonin and dopamine, the “stress hormone” cortisol, and other molecules that affect neurological health, mood, stress response, and focus. Backed by more than 18 clinical studies, PS128™ continues to be studied for how it may support this connection between gut health and overall wellbeing.
At the same time, the brand has reported good news in other key markets: Neuralli™ MP has officially completed notification with Singapore’s Health Sciences Authority (HSA) as a notified health supplement (VNS Notification No.: VNS-2026-08-00377), and now offers full support for Health Savings Account (HSA) and Flexible Spending Account (FSA) payments in the US market, allowing local consumers to purchase the product using pre-tax health benefit funds. These international milestones echo the professional recognition earned in Hong Kong, together reinforcing the brand’s leading position in global Brain-Gut Axis research.
Looking ahead, Bened Life will continue to deepen its local presence and scientific outreach across the APAC region, providing consumers worldwide with psychobiotic solutions backed by scientific research and high quality standards, and leading new trends in global brain and mental wellness.
About Bened Life
Bened Life is a US-based leader in psychobiotics, focused on Gut-Brain Axis research. The company is committed to developing the world’s first medical-grade Gut-Brain Axis probiotic solutions, grounded in scientific evidence and clinical data. Its flagship product, Neuralli™ MP, features the patented strain PS128™, supported by 18 clinical studies, and is sold in over 60 countries and regions worldwide. Guided by its mission of “science-driven health,” Bened Life continues to expand its presence in core markets including the US and Asia-Pacific, while actively investing in neurodiversity initiatives and research collaborations, committed to providing consumers worldwide with trustworthy mental wellness supplements. For more information, please visit Bened Life’s official website.
¹ Out of 45 surveyed HCPs, 41 (91.1%) recommended this product.
² Out of 45 surveyed HCPs, 35 self-rated their baseline focus as 6 or below; results are based on this group.
³ Out of 45 surveyed HCPs, 29 indicated experiencing high recent work stress before the trial; results are based on this group.
*This survey reflects subjective satisfaction feedback from respondents, is not a clinical trial result, and does not constitute medical diagnosis or advice.
*Note: “Medical Food” refers to an official regulatory category defined under U.S. FDA guidelines.
